Identification of promoter-binding proteins of the fbp A and C genes in Mycobacterium tuberculosis

Tuberculosis

Volumn 90, Issue 1, 2010, Pages 25-30

  Romero, Ibeth C ^a   Mehaffy, Carolina ^b   Burchmore, Richard J ^c   Dobos Elder, Karen ^b   Brennan, Patrick ^b   Walker, John ^a  

^a CENTRO INTERNACIONAL DE ENTRENAMIENTO E INVESTIGACIONES MÉDICAS CIDEIM   (Colombia)

^b Department of Environmental and Radiological Health Sciences   (United States)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Antigen 85; Gene activators; Isoniazid; MarR transcriptional regulator; Mycobacterium tuberculosis

Indexed keywords

ANTIGEN 85; BACTERIAL ANTIGEN; FIBRONECTIN BINDING PROTEIN; ISONIAZID; STREPTAVIDIN; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; BACTERIUM CULTURE; BIOSYNTHESIS; BIOTINYLATION; CELL DIVISION; CELL INTERACTION; CELL WALL; DNA BINDING; DRUG TARGETING; FBP A GENE; FBP C GENE; GENE; GENE ACTIVATION; GENE OVEREXPRESSION; GENE SEQUENCE; MACROPHAGE; MASS SPECTROMETRY; MOLECULAR CLONING; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN METABOLISM; TRANSCRIPTION REGULATION; TREATMENT RESPONSE;

ACYLTRANSFERASES; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; CELL WALL; DNA-BINDING PROTEINS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; GENE AMPLIFICATION; HUMANS; MASS SPECTROMETRY; MEMBRANE TRANSPORT PROTEINS; MOLECULAR SEQUENCE DATA; MYCOBACTERIUM TUBERCULOSIS; PROMOTER REGIONS, GENETIC; TRANSCRIPTION FACTORS; TUBERCULOSIS; UP-REGULATION;

EID: 75549086229     PISSN: 14729792     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tube.2009.10.001     Document Type: Article

References (42)

1. Acosta-Viana K.Y., and Zavala-Castro J.E. Proteínas de unión a ADN. Rev Biomed 7 (1996) 163-172
2. Alekshun M.N., and Levy S.B. Regulation of chromosomally mediated multiple antibiotic resistance: the mar regulon. Antimicrob Agents Chemother 41 (1997) 2067-2075
3. Alekshun M.N., and Levy S.B. The mar regulon: multiple resistance to antibiotics and other toxic chemicals. Trends Microbiol 7 (1999) 410-413
4. Alekshun M.N., Kim Y.S., and Levy S.B. Mutational analysis of MarR, the negative regulator of marRAB expression in Escherichia coli, suggests the presence of two regions required for DNA binding. Mol Microbiol 35 (2000) 1394-1404
5. Alekshun M.N., Levy S.B., Mealy T.R., Seaton B.A., and Head J.F. The crystal structure of MarR, a regulator of multiple antibiotic resistance at 2.3 Å resolution. Nat Struc Biol 8 (2001) 710-714
6. Armitige L., Jagannath C., Wanger A., and Norris S. Disruption of the genes encoding antigen 85A and antigen 85B of Mycobacterium tuberculosis H37Rv: effect on growth in culture and in macrophages. Infect Immun 68 (2000) 767-778
7. Asante-Appiah E., and Skalka A.M. HIV-1 integrase: structural organization, conformational changes, and catalysis. Adv Virus Res 52 (1999) 351-369
8. Barbosa T.M., and Levy S.B. Differential expression of over 60 chromosomal genes in Escherichia coli by constitutive expression of MarA. J Bacteriol 182 (2000) 3467-3474
9. Bastian I., Rigouts L., Palomino J.C., and Portaels F. Kanamycin susceptibility testing of Mycobacterium tuberculosis using mycobacterium growth indicator tube and a colorimetric method. Antimicrob Agents Chemother 45 (2001) 1934-1940
10. Belisle J.T., Vissa V.D., Sievert T., Takayama K., Brennan P.J., and Besra G.S. Role of the major antigen of Mycobacterium tuberculosis in cell wall biogenesis. Science 276 (1997) 1420-1422
11. Carvalho H., and Meneghini R. Increased expression and purification of soluble iron-regulatory protein 1 from Escherichia coli co-expressing chaperonins GroES and GroEL. Braz J Med Biol Res 41 (2008) 270-276
12. Chelikani P., Fita I., and Loewen P.C. Diversity of structures and properties among catalases. Cell Mol Life Sci 61 (2004) 192-208
13. Content J., Cuvellerie A., Wit L., Vincent-Levy-Frébault V., Ooms J., and Bruyn J. The genes coding for the antigen 85 Complexes of Mycobacterium tuberculosis and Mycobacterium bovis BCG are members of a gene family: cloning, sequence determination and genomic organization of the gene coding for antigen 85-C of M. tuberculosis. Infect Immun 59 (1991) 3205-3212
14. Dyda F., Hickman A.M., Jenkins T.M., Engelman A., Craigie R., and Davies D.R. Crystal structure of the catalytic domain of HIV-1 integrase: similarity to other polynucleotidyl transferases. Science 266 (1994) 1981-1986
15. Farnia P., Mohammadi F., Mirsaedi M., Zarife A.Z., Tabatabee J., Bahadori K., et al. Application of oxidation-reduction assay for monitoring treatment of patients with pulmonary tuberculosis. J C Microbiol 42 (2004) 3324-3325
16. Garbe T., Hibler N., and Deretic V. Isoniazid Induces expression of the antigen 85 complex in Mycobacterium tuberculosis. Antimicrob Agents Chemother 40 (1996) 1754-1756
17. Gerstmeir R., Cramer A., Dangelj P., Schaffer S., and Eikmanns B. RamB, a novel transcriptional regulator of genes involved in acetate metabolism of Corynebacterium glutamicum. J Bacteriol 186 (2004) 2798-2809
18. Giometti C.S., Gemmell A., Tollaksen S.L., and Taylor J. Quantitation of human leukocyte proteins after silver staining: a study with two-dimensional electrophoresis. Electrophoresis 12 (1991) 536-543
19. Góngora R., Acestor N., Quadroni M., Fasel N., Saravia N.G., and Walker J. Mapping the proteome of Leishmania Viannia using two-dimensional polyacrylamide gel electrophoresis and associated technologies. Biomédica 23 (2003) 153-160
20. Gupta P., Aggarwal N., Batra P., Mishra S., and Chaudhuri T.K. Co-expression of chaperonin GroEL/GroES enhances in vivo folding of yeast mitochondrial aconitase and alters the growth characteristics of Escherichia coli. Int J Biochem Cell Biol 38 (2006) 1975-1985
21. Harth G., Horwitz M.A., Tabatadze D., and Zamecnick P.C. Targeting the Mycobacterium tuberculosis 30/32-kDa mycolyl transferase complex as a therapeutic strategy against tuberculosis: proof of principle by using antisense technology. Proc Natl Acad Sci USA 99 (2002) 15614-15619
22. Hazbon M.H., Brimacombe M., Bobadilla del Valle M., Cavatore M., Inirida Guerrero M., Varma-Basil M., et al. Population genetics study of Isoniazid resistance mutations and evolution of multidrug-resistant Mycobacterium tuberculosis. Antimicrob Agents Chemother 50 (2006) 2640-2649
23. Islam N., Kanost A., Teixeira L., Johnson J., Hejal R., Aung H., et al. Role of cellular activation and tumor necrosis factor-a in the early expression of Mycobacterium tuberculosis 85B mRNA in human alveolar macrophagues. J Infect Dis 190 (2004) 341-351
24. Jackson M., Raynaud C., Raynaud M.A., Guilhot C., Laurent-Winter C., Ensergueix D., et al. Inactivation of the antigen 85C gene profoundly affects content and alters the permeability of the Mycobacterium tuberculosis cell envelope. Mol Microbiol 31 (1999) 1573-1587
25. Keeney D., Ruzin A., McAleese F., Murphy E., and Bradford P.A. MarA-mediated overexpression of the AcrAB efflux pump results in decreased susceptibility to tigecycline in Escherichia coli. J Antimicrob Chemother 61 (2007) 46-53
26. Kremer L., Baulard A., Estaquier J., Content J., Capron A., and Locht C. Analysis of the Mycobacterium tuberculosis 85A antigen promoter region. J Bacteriol 177 (1995) 642-653
27. Lynett J., and Stokes R.W. Selection of transposon mutants of Mycobacterium tuberculosis with increased macrophage infectivity identifies fadD23 to be involved in sulfolipid production and association with macrophages. Microbiology 153 (2007) 3133-3140
28. Mutapi F., Burchmore R., Mduluza T., Foucher A., Harcus Y., Nicoll G., et al. Praziquantel treatment of individuals exposed to Schistosoma haematobium enhances serological recognition of defined parasite antigens. J Infect Dis 192 (2005) 1108-1118
29. Nagy J.M., Cass A.E.G., and Brown K.A. Purification and characterization of recombinant catalase-peroxidase, which confers isoniazid sensitivity in Mycobacterium tuberculosis. J Biol Chem 272 (1997) 31265-31271
30. Ohara N., Ohara-Wada N., Kitaura H., Nishiyama T., Matsumoto S., and Yamada T. Analysis of the genes encoding the antigen 85 complex and MPT51 from Mycobacterium avium. Infect Immun 65 (1997) 3680-3685
31. Qamra R., Srinivas V., and Mande M.S. Mycobacterium tuberculosis GroEL homologues unusually exist as lower oligomers and retain the ability to suppress aggregation of substrate proteins. J Mol Biol 342 (2004) 605-617
32. Ramaswamy S.V., Reich R., Dou S.-J., Jasperse L., Pan X., Wanger A., et al. Single nucleotide polymorphisms in genes associated with isoniazid resistance in Mycobacterium tuberculosis. Antimicrob Agents Chemother 47 (2003) 1241-1250
33. Sinha P., Poland J., Schnolzer M., and Rabilloud T. A new silver staining apparatus and procedure for matrix-assisted laser desorption/ionizationtime- of-flight analysis of proteins after two-dimensional electrophoresis. Proteomics 1 (2001) 835-840
34. Smith P.K., Krohn R.I., Hermanson G.T., Mallia A.K., Gartner F.H., Provenzano M.D., et al. Measurement of protein using bicinchoninic acid. Anal Biochem 150 (1985) 76-85
35. Tegmark K., Karlsson A., and Arvidson S. Identification and characterization of SarH1, a new global regulator of virulence gene expression in Staphylococcus aureus. Mol Microbiol 37 (2000) 398-409
36. Tu Z.-L., Li J.-N., Chin K.-H., Chou C.-C., Lee C.-C., Shr H.-L., et al. Cloning, expression, crystallization and preliminary X-ray analysis of a putative multiple antibiotic resistance repressor protein (MarR) from Xanthomonas campestris. Acta Cryst. 61 (2005) 706-708
37. WHO (World Health Organization). REPORT. Global tuberculosis control: surveillance, planning, financing. Geneva, World Health Organization. [Online] http://www.who.int/tb/publications/global_report/2006/en/index.html.
38. Wilkinson R., DesJardin L., Islam N., Gibson B., Kanost R., Wilkinson K., et al. An Increase in expression of Mycobacterium tuberculosis mycolyl transferase gene (fbpB) occurs early after infection of human monocytes. Mol Microbiol 39 (2001) 813-821
39. Wilson M., Derisi J., Kristensen H.H., Imboden P., Rane S., Brown P.O., et al. Exploring drug-induced alterations in gene expression in Mycobacterium tuberculosis by microarray hybridization. Proc Natl Acad Sci USA 96 (1999) 12833-12838
40. Wu R., Zhang R., Zagnitko O., Dementieva I., Maltzev N., Watson J.D., et al. Crystal structure of Enterococcus faecalis SlyA-like transcriptional factor. J Biol Chem 278 (2003) 20240-20244
41. Zhang Y., and Amzel L.M. Tuberculosis drug targets. Cur Drug Targets 3 (2002) 131-154
42. Zheng R., Jenkins T.M., and Craigie R. Zinc folds the N-terminal domain of HIV-1 integrase, promotes multimerization, and enhances catalytic activity. Proc Natl Acad Sci.USA 93 (1996) 13659-13664